Yes, it is excellent news.
Makes me think back to the days when certain posters said we could never advance to Phase 3 based on previous results.
Not only did we advance....we now have a clear path to registering a new drug with the FDA. Note that the registration may be CVD or possibly even renal.
All we need are some positive results now.
I would think more analyst coverage will be on the way.
bfw